X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (127) 127
index medicus (90) 90
hematology (82) 82
male (81) 81
female (71) 71
middle aged (69) 69
aged (68) 68
oncology (65) 65
chronic lymphocytic leukemia (57) 57
article (46) 46
prognosis (45) 45
rituximab (44) 44
aged, 80 and over (43) 43
leukemia, lymphocytic, chronic, b-cell - drug therapy (42) 42
adult (41) 41
leukemia, lymphocytic, chronic, b-cell - pathology (31) 31
treatment outcome (31) 31
cancer (26) 26
hemic and lymphatic diseases (26) 26
cll (25) 25
leukemia, lymphocytic, chronic, b-cell - diagnosis (25) 25
leukemia, lymphocytic, chronic, b-cell - genetics (24) 24
survival (22) 22
antineoplastic combined chemotherapy protocols - therapeutic use (21) 21
fludarabine (21) 21
abridged index medicus (20) 20
therapy (20) 20
disease progression (19) 19
leukemia, lymphocytic, chronic, b-cell - complications (19) 19
leukemia, lymphocytic, chronic, b-cell - mortality (19) 19
neoplasm staging (19) 19
care and treatment (18) 18
alemtuzumab (17) 17
chronic lymphocytic-leukemia (17) 17
cyclophosphamide (17) 17
leukemia, lymphocytic, chronic, b-cell - therapy (17) 17
survival analysis (17) 17
antineoplastic agents - therapeutic use (16) 16
chemoimmunotherapy (16) 16
cohort studies (16) 16
diagnosis (15) 15
leukemia, lymphocytic, chronic, b-cell - immunology (15) 15
antibodies, monoclonal, murine-derived (14) 14
cd38 expression (14) 14
immune system diseases (14) 14
in situ hybridization, fluorescence (14) 14
lymphomas (14) 14
b-cells (13) 13
chronic lymphocytic leukaemia (13) 13
lymphoma (13) 13
retrospective studies (13) 13
risk factors (13) 13
follow-up studies (12) 12
hematology, oncology and palliative medicine (12) 12
research (12) 12
small lymphocytic lymphoma (12) 12
survival rate (12) 12
antineoplastic combined chemotherapy protocols - adverse effects (11) 11
apoptosis (11) 11
guidelines (11) 11
lymphocyte count (11) 11
antibodies, monoclonal - administration & dosage (10) 10
antibodies, monoclonal - therapeutic use (10) 10
immunology (10) 10
immunotherapy (10) 10
in-situ hybridization (10) 10
leukemia (10) 10
b-lymphocytes - immunology (9) 9
chemotherapy (9) 9
diagnosis, differential (9) 9
disease-free survival (9) 9
antibodies, monoclonal - adverse effects (8) 8
antineoplastic agents - adverse effects (8) 8
chromosome deletion (8) 8
classification (8) 8
drug administration schedule (8) 8
flow cytometry (8) 8
in-vitro (8) 8
recurrence (8) 8
risk (8) 8
b-lymphocytes - pathology (7) 7
cells (7) 7
chlorambucil (7) 7
combined modality therapy (7) 7
cyclophosphamide - administration & dosage (7) 7
disease (7) 7
fludarabine plus cyclophosphamide (7) 7
hemolytic-anemia (7) 7
immunoglobulin heavy chains - genetics (7) 7
immunophenotyping (7) 7
leukemia, lymphocytic, chronic, b-cell - blood (7) 7
natural-history (7) 7
prospective studies (7) 7
t-cells (7) 7
time factors (7) 7
variable-region mutations (7) 7
activation (6) 6
antibodies, monoclonal, humanized (6) 6
biopsy (6) 6
chromosome aberrations (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Leukemia & Lymphoma, ISSN 1042-8194, 05/2016, Volume 57, Issue 5, pp. 985 - 986
Journal Article
The FEBS Journal, ISSN 1742-464X, 04/2017, Volume 284, Issue 7, pp. 1021 - 1039
The phagocytic clearance of host cells is important for eliminating dying cells and for the therapeutic clearance of antibody‐targeted cells. As ubiquitous,... 
phagocytosis | chronic lymphocytic leukemia | lymphoid malignancy | cellular metabolism | efferocytosis | apoptosis | macrophage | monoclonal antibody therapy | GTPase | RESIDENT PERITONEAL-MACROPHAGES | RHO-FAMILY GTPASES | PHOSPHATIDYLSERINE RECEPTOR | DENDRITIC CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | MEDIATED PHAGOCYTOSIS | ANTIBODY-DEPENDENT PHAGOCYTOSIS | APOPTOTIC CELLS | CHRONIC LYMPHOCYTIC-LEUKEMIA | RED-BLOOD-CELLS | RECEPTOR TYROSINE KINASE | Phagocytosis - drug effects | Signal Transduction | Apoptosis - drug effects | Antibodies, Monoclonal - pharmacology | Coculture Techniques | Humans | Receptors, Fc - metabolism | GTPase-Activating Proteins - metabolism | Macrophages - cytology | Transcription Factors - genetics | DNA-Binding Proteins - genetics | DNA-Binding Proteins - metabolism | Gene Expression Regulation - drug effects | Transcription Factors - metabolism | Animals | Macrophages - drug effects | Receptors, Fc - genetics | GTPase-Activating Proteins - genetics | Phospholipids - metabolism | Tumor Cells, Cultured | Macrophages - immunology | rac1 GTP-Binding Protein - metabolism | rac1 GTP-Binding Protein - genetics | Monoclonal antibodies | Macrophages | Biological products | Metabolism | Pathogens | Phagocytes | Molecular modelling | Internalization | Immune clearance | Antibodies | Phagocytosis | Apoptosis | Immune system | Chronic Lymphocytic Leukemia | Cellular metabolism | Efferocytosis | Lymphoid malignancy | Monoclonal antibody therapy | Macrophage
Journal Article
Leukemia & lymphoma, ISSN 1042-8194, 01/2020, pp. 1 - 15
Chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) is associated with increased risk for certain cancers, but relatively little is known about... 
Journal Article
Blood, ISSN 0006-4971, 05/2010, Volume 115, Issue 21, pp. 4154 - 4155
Chronic lymphocytic leukemia (CLL) patients with p53 pathway dysfunction have poor responses to conventional chemoimmunotherapy and short survival. This small... 
CHRONIC LYMPHOCYTIC-LEUKEMIA | NETWORK | MIR-34A | HEMATOLOGY | SNP309 | DELETION
Journal Article
American journal of hematology, ISSN 0361-8609, 01/2020
Journal Article
American Journal of Hematology, ISSN 0361-8609, 01/2020, Volume 95, Issue 1, pp. E16 - E18
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2016, Volume 128, Issue 18, pp. 2199 - 2205
Journal Article
Journal Article
American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting, 2015, pp. 164 - 175
Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) is usually diagnosed in asymptomatic patients with early-stage disease. The standard management... 
Leukemia, Lymphocytic, Chronic, B-Cell - therapy | Recurrence | Humans | Leukemia, Lymphocytic, Chronic, B-Cell - etiology | Disease Management | Neoplasm Staging | Leukemia, Lymphocytic, Chronic, B-Cell - complications | Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis
Journal Article
American Journal of Hematology, ISSN 0361-8609, 09/2017, Volume 92, Issue 9, pp. E542 - E544
Journal Article
Blood, ISSN 0006-4971, 05/2013, Volume 121, Issue 20, pp. 4137 - 4141
Journal Article
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 3203 - 3203
Abstract Introduction: Infection is a major source of morbidity and mortality in CLL. Improved treatment efficacy and decreased immune toxicity of treatment... 
Journal Article